Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: J Neurooncol. 2016 Jan 4;127(2):329–335. doi: 10.1007/s11060-015-2037-1

Fig. 2.

Fig. 2

Severe treatment-related lymphopenia in elderly patients with GBM is associated with reduced overall survival. Kaplan–Meier survival curves for elderly patients with GBM who have undergone chemo/RT are depicted below. Patients who developed severe treatment-related lymphopenia (TLC<500 cells/mm3) 2 months after beginning chemo/RT had a significant shorter median overall survival than those whose TLC were ≥500 cells/mm3 (multivariate analysis HR 2.76, 95 %CI 1.30–5.86, p = 0.008)